Screening for Early Evidence of Diabetes
Public ClinicalTrials.gov record NCT00614783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-Center, Paired Data, Cohort Screening Trial Comparing SCOUT to the Fasting Plasma Glucose Test in Subjects at Risk for Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.
Study identification
- NCT ID
- NCT00614783
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 3,478 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Dec 2010 (Actual)
- Completion
- Dec 2010 (Actual)
- Last update posted
- Dec 4, 2012
2007 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Accelovance | Huntsville | Alabama | 35802 | — |
| Accelovance | San Diego | California | 92108 | — |
| Veteran's Administration Hospital | San Diego | California | 92161 | — |
| MedStar Research Institute | Washington D.C. | District of Columbia | 20003 | — |
| Kaiser Permanente-Center for Health Research | Honolulu | Hawaii | 96813 | — |
| Radiant Research | Chicago | Illinois | 60610 | — |
| Accelovance | Peoria | Illinois | 61602 | — |
| Radiant Research | Overland Park | Kansas | 66202 | — |
| Radiant Research | Edina | Minnesota | 55435 | — |
| Lovelace Scientific Resources | Albuquerque | New Mexico | 87108 | — |
| New York Hospital Queens-Lang Research Center | Flushing | New York | 11355 | — |
| Radiant Research | Cincinnati | Ohio | 45249 | — |
| Oklahoma Diabetes Center, University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Diabetes and Lipid Research, University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Radiant Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00614783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2012 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00614783 live on ClinicalTrials.gov.